T. Rowe Price Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $634M | Sell |
16,048,721
-126,812
| -0.8% | -$5.01M | 0.4% | 65 |
|
|
2025
Q1 | $488M | Buy |
16,175,533
+2,006,334
| +14% | +$60.5M | 0.32% | 89 |
|
|
2024
Q4 | $495M | Buy |
14,169,199
+1,083
| +0% | +$37.9K | 0.31% | 95 |
|
|
2024
Q3 | $568M | Buy |
14,168,116
+1,528,432
| +12% | +$61.2M | 0.34% | 84 |
|
|
2024
Q2 | $602M | Sell |
12,639,684
-677,428
| -5% | -$32.3M | 0.38% | 74 |
|
|
2024
Q1 | $577M | Buy |
13,317,112
+115,659
| +0.9% | +$5.01M | 0.35% | 78 |
|
|
2023
Q4 | $668M | Buy |
13,201,453
+78,398
| +0.6% | +$3.97M | 0.43% | 72 |
|
|
2023
Q3 | $595M | Buy |
13,123,055
+39,328
| +0.3% | +$1.78M | 0.42% | 68 |
|
|
2023
Q2 | $537M | Buy |
13,083,727
+19,680
| +0.2% | +$807K | 0.37% | 80 |
|
|
2023
Q1 | $467M | Buy |
13,064,047
+1,385,788
| +12% | +$49.5M | 0.33% | 85 |
|
|
2022
Q4 | $441M | Buy |
11,678,259
+521,564
| +5% | +$19.7M | 0.34% | 86 |
|
|
2022
Q3 | $493M | Buy |
+11,156,695
| New | +$493M | 0.39% | 72 |
|